medRxiv PreprintsInternational16 November 2026
Role of Intravenous Tranexamic Acid in Immediate Breast Reconstruction with an Extended Latissimus Dorsi Flap: A Retrospective Cohort Study
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: The purpose of this study was to assess the impact of intravenous tranexamic acid (TXA) on postoperative drainage, laboratory parameters, and complications in patients undergoing immediate extended latissimus dorsi (ELD) flap breast reconstruction. Methods: This retrospective cohort study included 82 patients who underwent immediate ELD flap breast reconstruction between January 2019 and May 2026. The TXA group (n = 42) received 1 g of intravenous TXA at the start of surgery after its routine adoption in July 2021; the control group (n = 40) underwent surgery before this date witho
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.